|
1
|
Engstrand J, Nilsson H, Stromberg C, Jonas
E and Freedman J: Colorectal cancer liver metastases - a
population-based study on incidence, management and survival. BMC
Cancer. 18:782018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang Y, Zhong X, He X, Hu Z, Huang H, Chen
J, Chen K, Zhao S, Wei P and Li D: Liver metastasis from colorectal
cancer: Pathogenetic development, immune landscape of the tumour
microenvironment and therapeutic approaches. J Exp Clin Cancer Res.
42:1772023. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sathe A, Mason K, Grimes SM, Zhou Z, Lau
BT, Bai X, Su A, Tan X, Lee H, Suarez CJ, et al: Colorectal cancer
metastases in the liver establish immunosuppressive spatial
networking between tumor-associated SPP1+ macrophages and
fibroblasts. Clin Cancer Res. 29:244–260. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Walcher L, Kistenmacher AK, Suo H, Kitte
R, Dluczek S, Strauß A, Blaudszun AR, Yevsa T, Fricke S and
Kossatz-Boehlert U: Cancer stem cells-origins and biomarkers:
Perspectives for targeted personalized therapies. Front Immunol.
11:12802020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chinese College of Surgeons, Section of
Gastrointestinal Surgery, Branch of Surgery, Chinese Medical
Association, Section of Colorectal Surgery, Branch of Surgery,
Chinese Medical Association, Colorectal Cancer Professional
Committee, Chinese Anti-Cancer Association and Colorectal Cancer
Professional Committee et al, . China guideline for diagnosis and
comprehensive treatment of colorectal liver metastases (version
2023). Zhonghua Wei Chang Wai Ke Za Zhi. 26:1–15. 2023.(In
Chinese). PubMed/NCBI
|
|
6
|
Cremolini C, Antoniotti C, Stein A,
Bendell J, Gruenberger T, Rossini D, Masi G, Ongaro E, Hurwitz H,
Falcone A, et al: Individual patient data meta-analysis of
FOLFOXIRI plus bevacizumab versus doublets plus bevacizumab as
initial therapy of unresectable metastatic colorectal cancer. J
Clin Oncol. Aug 20–2020.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Song W, Tiruthani K, Wang Y, Shen L, Hu M,
Dorosheva O, Qiu K, Kinghorn KA, Liu R and Huang L: Trapping of
lipopolysaccharide to promote immunotherapy against colorectal
cancer and attenuate liver metastasis. Adv Mater. 30:e18050072018.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Weber M, Lam M, Chiesa C, Konijnenberg M,
Cremonesi M, Flamen P, Gnesin S, Bodei L, Kracmerova T, Luster M,
et al: EANM procedure guideline for the treatment of liver cancer
and liver metastases with intra-arterial radioactive compounds. Eur
J Nucl Med Mol Imaging. 49:1682–1699. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mimmo A, Pegoraro F, Rhaiem R, Montalti R,
Donadieu A, Tashkandi A, Al-Sadairi AR, Kianmanesh R and Piardi T:
Microwave ablation for colorectal liver metastases: A systematic
review and pooled oncological analyses. Cancers (Basel).
14:13052022. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Orsi F and Varano G: Minimal invasive
treatments for liver malignancies. Ultrason Sonochem. 27:659–667.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
De Maio A, Alfieri G, Mattone M, Ghanouni
P and Napoli A: High-Intensity focused ultrasound surgery for tumor
ablation: A review of current applications. Radiol Imaging Cancer.
6:e2300742024. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Padilla F, Foley J, Timbie K, Bullock TNJ
and Sheybani ND: Guidelines for immunological analyses following
focused ultrasound treatment. J Immunother Cancer. 11:e0074552023.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sheybani ND, Batts AJ, Mathew AS, Thim EA
and Price RJ: Focused ultrasound hyperthermia augments release of
glioma-derived extracellular vesicles with differential
immunomodulatory capacity. Theranostics. 10:7436–7447. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ashar H, Singh A, Kishore D, Neel T, More
S, Liu C, Dugat D and Ranjan A: Enabling chemo-immunotherapy with
HIFU in canine cancer patients. Ann Biomed Eng. 52:1859–1872. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ning Z, Xie J, Chen Q, Zhang C, Xu L, Song
L and Meng Z: HIFU is safe, effective, and feasible in pancreatic
cancer patients: A monocentric retrospective study among 523
patients. Onco Targets Ther. 12:1021–1029. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li K, Gong Y, Qiu D, Tang H, Zhang J, Yuan
Z, Huang Y, Qin Y, Ye L and Yang Y: Hyperbaric oxygen facilitates
teniposide-induced cGAS-STING activation to enhance the antitumor
efficacy of PD-1 antibody in HCC. J Immunother Cancer.
10:e0040062022. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhu XH, Du JX, Zhu D, Ren SZ, Chen K and
Zhu HL: Recent research on methods to improve tumor hypoxia
environment. Oxid Med Cell Longev. 2020:57212582020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang Y, Tang Y, Du Y, Lin L, Zhang Z, Ou
X, Chen S, Wang Q and Zou J: Genetically engineered
bacteria-mediated multi-functional nanoparticles for synergistic
tumor-targeting therapy. Acta Biomater. 150:337–352. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mauri G, Nicosia L, Xu Z, Di Pietro S,
Monfardini L, Bonomo G, Varano GM, Prada F, Della Vigna P and Orsi
F: Focused ultrasound: tumour ablation and its potential to enhance
immunological therapy to cancer. Br J Radiol. 91:201706412018.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ran LF, Xie XP, Xia JZ, Xie FL, Fan YM and
Wu F: Specific antitumour immunity of HIFU-activated cytotoxic T
lymphocytes after adoptive transfusion in tumour-bearing mice. Int
J Hyperthermia. 32:204–210. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mauri G, Orsi F and Sconfienza LM:
Systemic effects of local tumor ablation: Oncogenesis and antitumor
induced immunity. Radiology. 283:9232017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
You Y, Wang Z, Ran H, Zheng Y, Wang D, Xu
J, Wang Z, Chen Y and Li P: Nanoparticle-enhanced synergistic HIFU
ablation and transarterial chemoembolization for efficient cancer
therapy. Nanoscale. 8:4324–4339. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Su F, Li J, Zhao X, Wang B, Hu Y, Sun Y
and Ji J: Interpretable tumor differentiation grade and
microsatellite instability recognition in gastric cancer using deep
learning. Lab Invest. 102:641–649. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang X, Landgraf L, Bailis N, Unger M,
Jochimsen TH and Melzer A: Image-guided high-intensity focused
ultrasound, a novel application for interventional nuclear
medicine? J Nucl Med. 62:1181–1188. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Luan S, Ji Y, Liu Y, Zhu L, Zhao H, Zhou
H, Li K, Zhu W and Zhu B: AI-powered ultrasonic thermometry for
HIFU therapy in deep organ. Ultrason Sonochem. 111:1071542024.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang K, Li Q, Xu J, Tang MX, Wang Z, Tsui
PH and Zhou X: Frequency-domain robust PCA for real-time monitoring
of HIFU treatment. IEEE Trans Med Imaging. 43:3001–3012. 2024.
View Article : Google Scholar : PubMed/NCBI
|
